Business Description
Cipher Pharmaceuticals Inc
NAICS : 325410
SIC : 3741
ISIN : CA17253X1050
Total Employee Number:
43Description
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 14.98 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | 26.81 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 10.67 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 35 | |||||
3-Year EBITDA Growth Rate | 26.4 | |||||
3-Year EPS without NRI Growth Rate | -0.5 | |||||
3-Year FCF Growth Rate | 40.9 | |||||
3-Year Book Growth Rate | 25.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.69 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.75 | |||||
9-Day RSI | 38.58 | |||||
14-Day RSI | 39.06 | |||||
3-1 Month Momentum % | -1.51 | |||||
6-1 Month Momentum % | 9.49 | |||||
12-1 Month Momentum % | 29.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 0.85 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 268.8 | |||||
Days Sales Outstanding | 79.16 | |||||
Days Payable | 213.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 6.6 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 81.63 | |||||
Operating Margin % | 39.23 | |||||
Net Margin % | 60.65 | |||||
EBITDA Margin % | 52.24 | |||||
FCF Margin % | 57.46 | |||||
OCF Margin % | 58.95 | |||||
ROE % | 26.08 | |||||
ROA % | 19.8 | |||||
ROIC % | 14.21 | |||||
3-Year ROIIC % | 5.36 | |||||
ROC (Joel Greenblatt) % | 1861.06 | |||||
ROCE % | 14.3 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 9.85 | |||||
Forward PE Ratio | 12.68 | |||||
PE Ratio without NRI | 10.2 | |||||
Shiller PE Ratio | 41.5 | |||||
Price-to-Owner-Earnings | 10.52 | |||||
PEG Ratio | 0.53 | |||||
PS Ratio | 6.01 | |||||
PB Ratio | 2.26 | |||||
Price-to-Tangible-Book | 6.76 | |||||
Price-to-Free-Cash-Flow | 10.43 | |||||
Price-to-Operating-Cash-Flow | 10.18 | |||||
EV-to-EBIT | 14.92 | |||||
EV-to-EBITDA | 10.87 | |||||
EV-to-Revenue | 5.68 | |||||
EV-to-Forward-Revenue | 5.32 | |||||
EV-to-FCF | 9.88 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 0.87 | |||||
Price-to-Median-PS-Value | 2.14 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.46 | |||||
Price-to-Graham-Number | 1.76 | |||||
| Price-to-Net-Current-Asset-Value | 61.16 | |||||
Earnings Yield (Greenblatt) % | 6.7 | |||||
FCF Yield % | 9.91 | |||||
Forward Rate of Return (Yacktman) % | 25.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CPHRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cipher Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 50.937 | ||
| EPS (TTM) ($) | 1.18 | ||
| Beta | 0.1959 | ||
| 3-Year Sharpe Ratio | 0.99 | ||
| 3-Year Sortino Ratio | 3.08 | ||
| Volatility % | 40.92 | ||
| 14-Day RSI | 39.06 | ||
| 14-Day ATR ($) | 0.221719 | ||
| 20-Day SMA ($) | 11.72009 | ||
| 12-1 Month Momentum % | 29.87 | ||
| 52-Week Range ($) | 8.6353 - 15 | ||
| Shares Outstanding (Mil) | 25.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cipher Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cipher Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 08:30 | In 130 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 129 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 08:30 | In 39 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 38 days | ||
| General meeting for 2026 | 2026-06-18 10:00 | 11.56 (-0.56%) | ||
| First quarter earnings conference call for 2026 | 2026-05-08 08:30 | 13.04 (-0.34%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 13.20 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-13 08:30 | 10.59 (+0.33%) | ||
| Annual report for 2025 | 2026-03-12 | 10.74 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-12 | 10.74 (+0.00%) |
Show
Entries
Cipher Pharmaceuticals Inc Frequently Asked Questions
What is Cipher Pharmaceuticals Inc(CPHRF)'s stock price today?
The current price of CPHRF is $11.62. The 52 week high of CPHRF is $15.00 and 52 week low is $8.64.
When is next earnings date of Cipher Pharmaceuticals Inc(CPHRF)?
The next earnings date of Cipher Pharmaceuticals Inc(CPHRF) is 2026-08-07 Est..
Does Cipher Pharmaceuticals Inc(CPHRF) pay dividends? If so, how much?
Cipher Pharmaceuticals Inc(CPHRF) does not pay dividend.
Guru Commentaries on OTCPK:CPHRF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Cipher Pharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers